By Matt Discombe2020-01-10T12:45:00
Trusts and clinical commissioning groups face new annual targets designed to combat rising levels of four bloodstream infections, but sanctions relating to MRSA and C difficile could be scrapped.
With a HSJ subscription you’ll unlock:
Already a subscriber? Sign into your account here
Part of HSJ Information Ltd. The White Chapel Building, 1st Floor, 10 Whitechapel High Street, London, E1 8QS. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud